Back to ISPOR Asia Pacific Summit 2026 Home
  Register
  • About
    • Why Attend
    • Registration Information
    • Marketing Kit
    • Attendee Resources
  • Short Courses
    • Short Courses
    • View All Short Courses
  • Program
    • Program
    • Learning Formats
    • Posters
    • Program Committee
  • Presenter Information
    • Speaker Resources
    • Poster Resources
  • Hotel & Venue
    • Hotel & Venue Information
    • Discover Bangkok 
large-circle

ISPOR Asia Pacific Summit 2026

6-8 September

  • Home
  • Events
  • Upcoming Conferences & Events
  • ISPOR Asia Pacific Summit 2026
  • Program
  • Program
  • Presentation
  • ACCELERATING ONCOLOGY EVIDENCE SYNTHESIS: A MULTI-LLM FRAMEWORK FOR AUTOMATED SYSTEMATIC LITERATURE REVIEW SCREENING...

    Jul 9, 2026, 19:56 PM
  • EARLY VERSUS LATE DISEASE UTILITY CAPTURE IN PRIMARY LATERAL SCLEROSIS: EVALUATING THE EQ-5D...

    Jul 9, 2026, 19:56 PM
  • AI-ASSISTED CPR SKILL ASSESSMENT: EVALUATING EFFECTIVENESS, EFFICIENCY, AND COST-EFFECTIVENESS IN CLINICAL TRAINING

    Jul 9, 2026, 19:56 PM
  • STAKEHOLDER PERSPECTIVES ON HA GO ADOPTION: A QUALITATIVE STUDY

    Jul 9, 2026, 19:56 PM
  • A STOCHASTIC SUBSET-SELECTION METHOD FOR ANCHORED POPULATION-ADJUSTED INDIRECT TREATMENT COMPARISONS: SWARM-ITC...

    Jul 9, 2026, 19:56 PM
  • IMPACT OF ANTIOXIDANT SUPPLEMENTATION ON QUALITY OF LIFE AND IGE LEVELS IN ALLERGIC RHINITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS...

    Jul 9, 2026, 19:56 PM
  • WILLINGNESS TO PAY AND MAXIMUM ACCEPTABLE RISK FOR SIX NON- OR PARTIAL-IMMUNIZATION PROGRAM VACCINES IN CHINA: A DISCRETE CHOICE EXPERIMENT

    Jul 9, 2026, 19:56 PM
  • STRUCTURED EXPERT ELICITATION TO INFORM CLINICAL EFFECTIVENESS OF EMERGING PHARMACEUTICALS IN “DIFFICULT-TO-TREAT” CROHN’S DISEASE...

    Jul 9, 2026, 19:56 PM
  • SUPPLY-CHAIN COST IMPLICATIONS OF ULTRA-LOW-TEMPERATURE VERSUS REFRIGERATION STABLE COVID-19 VACCINE FORMULATIONS IN BRAZIL...

    Jul 9, 2026, 19:56 PM
  • VARIABILITY AND INCONSISTENCY IN QOL ASSESSMENT IN JAPANESE ONCOLOGY HTA: A REVIEW OF PUBLIC AND MANUFACTURER ANALYSES

    Jul 9, 2026, 19:56 PM
  • ANALYSIS OF THE THEMATIC STRUCTURE AND INTENSITY DIFFERENCES IN CHINA'S NUCLEAR MEDICINE POLICY

    Jul 9, 2026, 19:56 PM
  • COST AVOIDANCE ASSOCIATED WITH HOSPITAL-COMPOUNDED PREPARATIONS IN A THAI TERTIARY HOSPITAL: A REAL-WORLD ECONOMIC ANALYSIS

    Jul 9, 2026, 19:56 PM
  • COST-EFFECTIVENESS ANALYSIS OF DURVALUMAB CONSOLIDATION TREATMENT AFTER CHEMORADIOTHERAPY FOR PATIENTS WITH LIMITED-STAGE SMALL-CELL LUNG CANCER IN JAPAN...

    Jul 9, 2026, 19:56 PM
  • COMPARATIVE COST-EFFECTIVENESS OF FIRST LINE THERAPY FOR METASTATIC OR RECURRENT PANCREATIC CANCER IN JAPAN

    Jul 9, 2026, 19:56 PM
  • A GUIDELINE-ALIGNED DEEP REINFORCEMENT LEARNING SYSTEM FOR SHORT- AND LONG-TERM THERAPEUTIC OUTCOME OPTIMIZATION IN ANTIDIABETIC THERAPY...

    Jul 9, 2026, 19:56 PM
  • AN EVALUATION OF TAIWAN’S NHIPHARMACLOUDSYSTEM FROM THE PERSPECTIVE OF ANTIBIOTIC STEWARDSHIP...

    Jul 9, 2026, 19:56 PM
  • OPERATIONALIZING ONCOLOGY AFFORDABILITY PROGRAMS: DEVELOPMENT OF AN IMPLEMENTATION AND PRIORITIZATION FRAMEWORK

    Jul 9, 2026, 19:56 PM
  • TO SYSTEMATICALLY EVALUATE THE APPLICATION OF ARTIFICIAL INTELLIGENCE IN COST-EFFECTIVENESS MODELING, AND ASSESS ITS IMPACT ON MODEL EFFICIENCY, ACCURACY, AND DECISION-MAKING IN HEALTH TECHNOLOGY ASSESSMENT (HTA)

    Jul 9, 2026, 19:56 PM
  • BULEVIRTIDE FOR CHRONIC HEPATITIS DELTA IN ROMANIA: A REAL-WORLD-DATA-DRIVEN COST-UTILITY AND BUDGET IMPACT ANALYSIS...

    Jul 9, 2026, 19:56 PM
  • THE SOCIOECONOMIC AND QUALITY OF LIFE IMPACT OF LIVING WITH RARE DISEASE ACROSS ASIAN COUNTRIES

    Jul 9, 2026, 19:56 PM
  • 1
  • 2
  • 3
  • 4
  • 5 (current)
  • 6
  • 7
  • 8
  • 9
  • 10
  • »
Quick Links

  • About
  • Media Center
  • Exhibits & Sponsorships
  • Contact Us
Policies & Legal

  • AI Policy
  • Antitrust Compliance
  • Code of Ethics
  • Cookie Policy
  • Diversity Policy
  • Funding Statement
  • Legal Disclaimer
  • Privacy Policy
  • Terms and Conditions

Subscribe

Join ISPOR


ISPOR–The Professional Society for
Health Economics and Outcomes Research

Copyright © 2018 ISPOR. All rights reserved.

International Society for Pharmacoeconomics and Outcomes Research, Inc

Website Design & Development by Matrix Group